Diagnostic Tests

Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample

Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample

By

MIT team develops simple, less painful diagnostic test for multiple myeloma using microfluidic chip and conventional blood sample.

Noninvasive 2-Gene Test Helps Distinguish Melanoma From Nonmelanoma

Noninvasive 2-Gene Test Helps Distinguish Melanoma From Nonmelanoma

By

Two-gene pigmented lesion test classifies skin lesions as melanoma or nonmelanoma, helping with diagnostic challenges faced with the visual image and pattern recognition approach.

Novel Blood Test Pinpoints Cancer Without Invasive Procedures

Novel Blood Test Pinpoints Cancer Without Invasive Procedures

By

A new blood test employs a type of DNA signature to locate the presence of tumor in a particular tissue, avoiding the need for invasive diagnostic procedures.

Nasal Biomarker in Smokers Could Predict Lung Cancer

Nasal Biomarker in Smokers Could Predict Lung Cancer

By

Novel diagnostic test determines whether suspicious lung lesions or nodules are malignant disease from a sample obtained via nasal swab.

Patient, Physician Preferences Inform Guidelines for Discussing Molecular Testing in Cancer Treatment

Patient, Physician Preferences Inform Guidelines for Discussing Molecular Testing in Cancer Treatment

By

Study identifies physician and patient preferences about information, who should communicate this information, and what guidelines should guide these discussions.

Breath Test Might Assist Detection of Stomach and Esophageal Cancers

Breath Test Might Assist Detection of Stomach and Esophageal Cancers

By

Research presented at the 2017 European Cancer Congress describes the potential of a noninvasive diagnostic test for esophageal and gastric cancers that measures chemicals in the breath.

Focus on Treatment Options Diminishes Patients' Understanding of Poor Prognosis

Focus on Treatment Options Diminishes Patients' Understanding of Poor Prognosis

By

The simple question: "Would you like to talk about what this means?" can lead to more thorough discussions about scan results and prognoses, better preparing patients to make informed treatment decisions.

Computer 'Deep Learning' Algorithm Matches Dermatologists at Classifying Melanomas

Computer 'Deep Learning' Algorithm Matches Dermatologists at Classifying Melanomas

By

Researchers compared the ability of an artificial-intelligence algorithm to recognize and classify skin cancers with the clinical evaluations of dermatologists.

Pathology Reports (Fact Sheet)

Pathology Reports (Fact Sheet)

This fact sheet examines pathology reports, including tissue collection methods, the ways in which tissue samples may be processed, and details typically included in such reports.

Recurrence Score Appears To Be Driving Personalized Treatment for Breast Cancer

Recurrence Score Appears To Be Driving Personalized Treatment for Breast Cancer

By

The recurrence score assay stratifies early stage, estrogen receptor-positive breast cancer by recurrence risk. This study assessed how clinicians use the recurrence score to recommend adjuvant systemic therapy or patients' experiences with testing decision-making.

Epigenetic Profiling Improves Identification of Primary Tumor in CUP

By

DNA methylation profiling identified the primary cancer in cases of cancer of unknown primary, informing tumor-type specific treatment that improved overall survival in these patients.

Ratio of Biomarkers on Imaging Identifies Aggressiveness of DCIS

By

A new technique combines imaging and mathematics to identify aggressive forms of ductal carcinoma in situ (DCIS), or stage 0 breast cancer, from nonaggressive varieties.

Computer Algorithm Matches Skilled Specialists in Detecting Early Esophageal Cancer

By

Using a computer algorithm to scan images of the esophagus for signs of early esophageal cancer is nearly as accurate as top specialists.

PET/CT Hybrid Imaging Technique Provides Accurate Guide for Prostate Cancer Biopsy

PET/CT Hybrid Imaging Technique Provides Accurate Guide for Prostate Cancer Biopsy

By

Prostate-specific molecular imaging at initial biopsy and preoperative planning can accurately determine and delineate the extent of prostate cancer. The imaging technique was a type of PET/CT called 68Ga-PSMA PET/CT.

Lung Cancer Signature Detected Via Breath Test Improves Early Diagnosis

Lung Cancer Signature Detected Via Breath Test Improves Early Diagnosis

By

Breath analysis offers an option for both primary screening and postsurgery monitoring of patients with lung cancer. Exhaled breath has certain carbonyl VOCs that indicate the presence of lung cancer in a process researchers hope will receive FDA approval.

New WHO Glioma Classification Can 'Optimize Patient Treatment Going Forward'

New WHO Glioma Classification Can 'Optimize Patient Treatment Going Forward'

By

The 2016 WHO Classification of Infiltrating Gliomas alters diagnostic criteria, providing the basis for clinical trial inclusion or exclusion based on an integrated diagnosis and setting the stage for all future research, according to a summary of 4 posters related to CNS biomarkers presented at the ASCO 2016 Annual Meeting.

Nuclear Imaging Offers Noninvasive Assessment of Early Stage Cervical Cancer

By

In patients with cervical cancer who do not have enlarged lymph nodes, SPECT-MRI imaging of their sentinel lymph nodes (SLNs) could assess whether metastases are present.

Urine Test Accurately Identifies Tumor Grade in Prostate Cancer

Urine Test Accurately Identifies Tumor Grade in Prostate Cancer

By

A new urine assay that can detect genetic changes correlated with prostate cancer correctly identified cancer grade in 92% of men with elevated PSA levels and high-grade cancers.

Altered Metabolism of Four Compounds Drives Glioblastoma Growth

By

The altered metabolism of methionine, tryptophan, kynurenine, and 5-methylthioadenosine can drive the development of glioblastoma. Results also suggest ways to treat the cancer, slow its growth, and precisely elucidate its extent.

Pill Improves Breast Imaging to Light Up Cancer

Pill Improves Breast Imaging to Light Up Cancer

By

Scientists are developing a pill that illuminates only cancerous tumors, improving on current methods that can identify tumors but cannot conclusively determine whether they are cancerous

Disparities Related to Race, Insurance, and Facility Type Affect Use of Genetic Assay in Breast Cancer

Disparities Related to Race, Insurance, and Facility Type Affect Use of Genetic Assay in Breast Cancer

By

Use and clinical implications of a test commonly used to predict the aggressiveness of early stage ER-positive breast cancer is influenced by patient's race, insurance, and type of facility.

Biomarker Tests Hindered by Lack of Sufficient Evidence and Regulation

By

Precision medicine aims to deliver the most appropriate treatment to individual patients; however, biomarker tests that are poorly validated or inappropriately applied could hinder administration of appropriate treatments, and in some cases motivate the use of harmful treatment.

Significant Gap in Sequencing Limits the Potential of Precision Medicine

By

Despite improvements in genomic sequencing technologies, a significant number of medically important genes are within genomic regions in which sequencing lacks the technical accuracy to generate reliable reads.

Metabolic Phenotyping of Blood Plasma Enables Lung Cancer Detection

Metabolic Phenotyping of Blood Plasma Enables Lung Cancer Detection

By

Unique metabolic biomarkers specific to lung cancer were found through metabolic phenotyping of blood plasma by proton nuclear magnetic resonance (H-NMR), enabling diagnosis of both early-stage and late-stage disease.

Imaging Analysis Nearly Matches Genetic Tests in Determining Need for Chemotherapy in Breast Cancer

By

A new analysis method for magnetic resonance imaging (MRI) data appears to reliably determine whether patients would need hormonal treatment only or also need chemotherapy.

Newly Approved NSCLC Diagnostic Assay Accurately Assesses for Treatment Options

By

An immunohistochemistry (IHC) test for rearrangements of the gene for anaplastic lymphoma kinase (ALK) receptor performed more accurately than another commonly used IHC assay, including reducing the rate of false positives.

Diagnostic Tool Can Smell Bladder Cancer or Prostate Cancer in a Urine Sample

Diagnostic Tool Can Smell Bladder Cancer or Prostate Cancer in a Urine Sample

By

Recent developments in a gas chromatography tool might allow doctors to determine whether urologic cancers are present via a urine sample.

Nanotechnology May Enable Detection of Biomarkers, Facilitate Cancer Diagnosis

By

A new technology detects disease biomarkers in the form of nucleic acids, which are the molecules that comprise DNA and RNA. The test zeroes in on microRNA, which can signal a wide range of diseases, including cancer.

Novel Technique Detects Persistent Leukemia in Patients Previously Thought to be in Remission

By

Persistent chronic myeloid leukemia in patients previously thought to be in remission can be detected with digital polymerase chain reaction.

<i>BRCA</i> Mutation Testing Rates on the Increase in Young Women

BRCA Mutation Testing Rates on the Increase in Young Women

Among young women diagnosed with breast cancer, frequency of testing 95 percent in 2013

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs